Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

BIZARRE: 2 - What They Never Told You

Medtronic's New Implant Could Transform Bladder Control Treatment

Innovative medical technologies are transforming healthcare by tackling chronic conditions that affect millions, offering hope and improved quality of life. The Food and Drug Administration (FDA) approved Medtronic plc’s (NYSE:MDT) Altaviva device on Friday.

Benzinga

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga

Medtronic's Hugo Robotic System Achieves 100% Success Rate In Hernia Repair Trial

Medtronic PLC (NYSE:MDT) released on Thursday results from the Enable Hernia Repair clinical study evaluating the performance of the Hugo robotic-assisted surgery (RAS) system in inguinal and ventral hernia repair procedures.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Medtronic Stock: Is MDT Outperforming the Healthcare Sector?

Medtronic has significantly outperformed the broader healthcare sector over the past year and in recent months, and analysts remain bullish on the stock’s prospects.

Barchart

Medtronic To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Medtronic Has Potential To Pursue Further Divestitures: Analyst

On Tuesday, Medtronic Plc (NYSE:MDT) reported second-quarter earnings and announced key board appointments after Elliott Investment Management became the company's largest shareholder.

Benzinga

These Analysts Boost Their Forecasts On Medtronic After Upbeat Q1 Earnings

Medtronic plc (NYSE:MDT) posted better-than-expected earnings for the first quarter and announced key board appointments on Tuesday, naming John Groetelaars and Bill Jellison as independent directors, effective immediately.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Nasdaq Down Over 300 Points; Medtronic Posts Upbeat Earnings

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1.5% on Tuesday.

Benzinga

Medtronic: The Opportunity Gets Healthier for Income Investors

Medtronic is on track to complete a market reversal in 2025. Sell-siders, including activists, analysts, and institutions, are buying this stock in 2025.

MarketBeat

Medtronic Lifts Annual Outlook, Appoints New Directors In Post-Elliott Strategic Shift

Medtronic plc (NYSE:MDT) announced key board appointments on Tuesday, naming John Groetelaars and Bill Jellison as independent directors, effective immediately. This move comes shortly after Elliott Investment Management became the company’s largest shareholder.

Benzinga

Stock Index Futures Muted as Focus Turns to Retail Earnings, U.S. Housing Data Awaited

September S&P 500 E-Mini futures (ESU25) are down -0.09%, and September Nasdaq 100 E-Mini futures (NQU25) are down -0.08% this morning as earnings from the nation’s retail heavyweights kicked off, shifting the focus to the strength of the American consumer.

Barchart

Medtronic Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Medtronic plc (NYSE:MDT) will release financial results for the first quarter before the opening bell on Tuesday, Aug. 19.

Benzinga

Are Wall Street Analysts Bullish on Medtronic Stock?

While Medtronic has struggled to keep up with the broader market over the past year, analysts remain fairly upbeat on its future growth prospects.

Barchart

Here's What to Expect From Medtronic's Next Earnings Report

Medtronic is all set to release its fiscal first-quarter earnings later next month, and analysts project earnings in line with the year-ago quarter.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Court Nixes Jury Award Over Medtronic's Heart Valve Infringement Claim

A federal appeals court has sided with Medtronic Plc (NYSE:MDT) in a long-running patent dispute, reversing a jury's finding that the company induced infringement of a Colibri Heart Valve LLC patent related to the implantation of artificial heart valves.

MarketBeat

5 Robotics Stocks to Buy for the Future of Automation

Robotics adoption is accelerating globally, with AI, automation, and real-time data processing reshaping industries from healthcare to manufacturing.

Benzinga

Medtronic Stock Is Climbing Friday: What's Going On?

On Wednesday, the Centers for Medicare Medicaid Services (CMS) proposed a significant step toward broader adoption of renal denervation (RDN) by offering coverage for both radiofrequency (rfRDN) and ultrasound (uRDN) technologies for uncontrolled hypertension. This coverage would be granted under a Coverage with Evidence Development (CED) framework, requiring treatment within…

Benzinga

Cathie Wood Vs. Jim Cramer: TV Host Says Top Ark AI Pick 'Losing Money Hand Over Fist'

When it comes to artificial intelligence stocks, there are multiple that are found in the various portfolios of Ark Funds, led by Cathie Wood.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

This $125M Israeli Startup Is Building The World's First Cataract Robot To Solve A Global Crisis: 'There Is No Human Way To Close The Gap'

ForSight Robotics, an Israeli startup aiming to automate cataract and eye surgery, announced Tuesday that it raised $125 million to expand its precision robotics platform, Oryom.

MarketBeat

3 Safe Buy-and-Hold Dividend Stocks With Strong Balance Sheets

These 3 dividend stocks offer strong balance sheets, low debt, and reliable payouts, making them solid long-term picks for income investors

MarketBeat

3 Stocks With 3% to 9% Yields Just Raised Dividends Again

See these stocks with hefty dividend yields that just boosted payouts further. One has a yield closing in on 10%, with even more upside potential per analysts.

Barchart

Why the Death Cross Could Be a Contrarian Signal for Medtronic (MDT)

Although MDT stock is about to flash an ominous technical indicator, quantitative-focused investors will want to keep Medtronic on their watch list.

Barchart

What Are Wall Street Analysts’ Target Price for Medtronic Stock?

While Medtronic has underperformed relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

MarketBeat

Medtronic: A Dividend Aristocrat With Stability and Innovation

Medtronic delivers consistent dividend growth and healthcare innovation, positioning it as a stable investment choice in today's dynamic market environment.

Kiplinger

Want to Live Longer? Here's What Works

With longevity science booming, you might make it to age 150. We separate the hype from proven strategies. Because the "science is extremely promising."

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.